Biochemistry and Pharmacology - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 5 of 5
  • Item
    Thumbnail Image
    An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid
    Wong, VK ; Baker, S ; Connor, TR ; Pickard, D ; Page, AJ ; Dave, J ; Murphy, N ; Holliman, R ; Sefton, A ; Millar, M ; Dyson, ZA ; Dougan, G ; Holt, KE (NATURE PORTFOLIO, 2016-10-05)
    The population of Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, exhibits limited DNA sequence variation, which complicates efforts to rationally discriminate individual isolates. Here we utilize data from whole-genome sequences (WGS) of nearly 2,000 isolates sourced from over 60 countries to generate a robust genotyping scheme that is phylogenetically informative and compatible with a range of assays. These data show that, with the exception of the rapidly disseminating H58 subclade (now designated genotype 4.3.1), the global S. Typhi population is highly structured and includes dozens of subclades that display geographical restriction. The genotyping approach presented here can be used to interrogate local S. Typhi populations and help identify recent introductions of S. Typhi into new or previously endemic locations, providing information on their likely geographical source. This approach can be used to classify clinical isolates and provides a universal framework for further experimental investigations.
  • Item
    Thumbnail Image
    Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy
    Britto, CD ; Dyson, ZA ; Duchene, S ; Carter, MJ ; Gurung, M ; Kelly, DF ; Murdoch, DR ; Ansari, I ; Thorson, S ; Shrestha, S ; Adhikari, N ; Dougan, G ; Holt, KE ; Pollard, AJ ; Ryan, ET (PUBLIC LIBRARY SCIENCE, 2018-04)
    BACKGROUND: Children are substantially affected by enteric fever in most settings with a high burden of the disease, including Nepal. However pathogen population structure and transmission dynamics are poorly delineated in young children, the proposed target group for immunization programs. Here we present whole genome sequencing and antimicrobial susceptibility data on 198 S. Typhi and 66 S. Paratyphi A isolated from children aged 2 months to 15 years of age during blood culture surveillance at Patan Hospital, Nepal, 2008-2016. PRINCIPAL FINDINGS: S. Typhi was the dominant agent and comprised several distinct genotypes, dominated by 4.3.1 (H58). The heterogeneity of genotypes in children under five was reduced compared to data from 2005-2006, attributable to ongoing clonal expansion of H58. Most isolates (86%) were non-susceptible to fluoroquinolones, associated mainly with S. Typhi H58 lineage II and S. Paratyphi A harbouring mutations in the quinolone resistance-determining region (QRDR); non-susceptible strains from these groups accounted for 50% and 25% of all isolates. Multi-drug resistance (MDR) was rare (3.5% of S. Typhi, 0 S. Paratyphi A) and restricted to chromosomal insertions of resistance genes in H58 lineage I strains. Temporal analyses revealed a shift in dominance from H58 Lineage I to H58 Lineage II, with the latter being significantly more common after 2010. Comparison to global data sets showed the local S. Typhi and S. Paratyphi A strains had close genetic relatives in other South Asian countries, indicating regional strain circulation. Multiple imports from India of ciprofloxacin-resistant H58 lineage II strains were identified, but these were rare and showed no evidence of clonal replacement of local S. Typhi. SIGNIFICANCE: These data indicate that enteric fever in Nepal continues to be a major public health issue with ongoing inter- and intra-country transmission, and highlights the need for regional coordination of intervention strategies. The absence of a S. Paratyphi A vaccine is cause for concern, given its prevalence as a fluoroquinolone resistant enteric fever agent in this setting.
  • Item
    Thumbnail Image
    The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa
    Park, SE ; Duy, TP ; Boinett, C ; Wong, VK ; Pak, GD ; Panzner, U ; Espinoza, LMC ; von Kalckreuth, V ; Im, J ; Schuett-Gerowitt, H ; Crump, JA ; Breiman, RF ; Adu-Sarkodie, Y ; Owusu-Dabo, E ; Rakotozandrindrainy, R ; Soura, AB ; Aseffa, A ; Gasmelseed, N ; Keddy, KH ; May, J ; Sow, AG ; Aaby, P ; Biggs, HM ; Hertz, JT ; Montgomery, JM ; Cosmas, L ; Olack, B ; Fields, B ; Sarpong, N ; Razafindrabe, TJL ; Raminosoa, TM ; Kabore, LP ; Sampo, E ; Teferi, M ; Yeshitela, B ; El Tayeb, MA ; Sooka, A ; Meyer, CG ; Krumkamp, R ; Dekker, DM ; Jaeger, A ; Poppert, S ; Tall, A ; Niang, A ; Bjerregaard-Andersen, M ; Lofberg, SV ; Seo, HJ ; Jeon, HJ ; Deerin, JF ; Park, J ; Konings, F ; Ali, M ; Clemens, JD ; Hughes, P ; Sendagala, JN ; Vudriko, T ; Downing, R ; Ikumapayi, UN ; Mackenzie, GA ; Obaro, S ; Argimon, S ; Aanensen, DM ; Page, A ; Keane, JA ; Duchene, S ; Dyson, Z ; Holt, KE ; Dougan, G ; Marks, F ; Baker, S (NATURE PORTFOLIO, 2018-11-30)
    There is paucity of data regarding the geographical distribution, incidence, and phylogenetics of multi-drug resistant (MDR) Salmonella Typhi in sub-Saharan Africa. Here we present a phylogenetic reconstruction of whole genome sequenced 249 contemporaneous S. Typhi isolated between 2008-2015 in 11 sub-Saharan African countries, in context of the 2,057 global S. Typhi genomic framework. Despite the broad genetic diversity, the majority of organisms (225/249; 90%) belong to only three genotypes, 4.3.1 (H58) (99/249; 40%), 3.1.1 (97/249; 39%), and 2.3.2 (29/249; 12%). Genotypes 4.3.1 and 3.1.1 are confined within East and West Africa, respectively. MDR phenotype is found in over 50% of organisms restricted within these dominant genotypes. High incidences of MDR S. Typhi are calculated in locations with a high burden of typhoid, specifically in children aged <15 years. Antimicrobial stewardship, MDR surveillance, and the introduction of typhoid conjugate vaccines will be critical for the control of MDR typhoid in Africa.
  • Item
    Thumbnail Image
    Persistent circulation of a fluoroquinolone-resistant Salmonella enterica Typhi clone in the Indian subcontinent
    Britto, CD ; Dyson, ZA ; Mathias, S ; Bosco, A ; Dougan, G ; Jose, S ; Nagaraj, S ; Holt, KE ; Pollard, AJ (OXFORD UNIV PRESS, 2020-02)
    BACKGROUND: The molecular structure of circulating enteric fever pathogens was studied using hospital-based genomic surveillance in a tertiary care referral centre in South India as a first genomic surveillance study, to our knowledge, of blood culture-confirmed enteric fever in the region. METHODS: Blood culture surveillance was conducted at St John's Medical College Hospital, Bengaluru, between July 2016 and June 2017. The bacterial isolates collected were linked to demographic variables of patients and subjected to WGS. The resulting pathogen genomic data were also globally contextualized to gauge possible phylogeographical patterns. RESULTS: Hospital-based genomic surveillance for enteric fever in Bengaluru, India, identified 101 Salmonella enterica Typhi and 14 S. Paratyphi A in a 1 year period. Ninety-six percent of isolates displayed non-susceptibility to fluoroquinolones. WGS showed the dominant pathogen was S. Typhi genotype 4.3.1.2 (H58 lineage II). A fluoroquinolone-resistant triple-mutant clone of S. Typhi 4.3.1.2 previously associated with gatifloxacin treatment failure in Nepal was implicated in 18% of enteric fever cases, indicating ongoing inter-regional circulation. CONCLUSIONS: Enteric fever in South India continues to be a major public health issue and is strongly associated with antimicrobial resistance. Robust microbiological surveillance is necessary to direct appropriate treatment and preventive strategies. Of particular concern is the emergence and expansion of the highly fluoroquinolone-resistant triple-mutant S. Typhi clone and its ongoing inter- and intra-country transmission in South Asia, which highlights the need for regional coordination of intervention strategies, including vaccination and longer-term strategies such as improvements to support hygiene and sanitation.
  • Item
    No Preview Available
    Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa
    Wong, VK ; Holt, KE ; Okoro, C ; Baker, S ; Pickard, DJ ; Marks, F ; Page, AJ ; Olanipekun, G ; Munir, H ; Alter, R ; Fey, PD ; Feasey, NA ; Weill, F-X ; Le Hello, S ; Hart, PJ ; Kariuki, S ; Breiman, RF ; Gordon, MA ; Heyderman, RS ; Jacobs, J ; Lunguya, O ; Msefula, C ; MacLennan, CA ; Keddy, KH ; Smith, AM ; Onsare, RS ; De Pinna, E ; Nair, S ; Amos, B ; Dougan, G ; Obaro, S ; Ryan, ET (PUBLIC LIBRARY SCIENCE, 2016-09)
    BACKGROUND: The burden of typhoid in sub-Saharan African (SSA) countries has been difficult to estimate, in part, due to suboptimal laboratory diagnostics. However, surveillance blood cultures at two sites in Nigeria have identified typhoid associated with Salmonella enterica serovar Typhi (S. Typhi) as an important cause of bacteremia in children. METHODS: A total of 128 S. Typhi isolates from these studies in Nigeria were whole-genome sequenced, and the resulting data was used to place these Nigerian isolates into a worldwide context based on their phylogeny and carriage of molecular determinants of antibiotic resistance. RESULTS: Several distinct S. Typhi genotypes were identified in Nigeria that were related to other clusters of S. Typhi isolates from north, west and central regions of Africa. The rapidly expanding S. Typhi clade 4.3.1 (H58) previously associated with multiple antimicrobial resistances in Asia and in east, central and southern Africa, was not detected in this study. However, antimicrobial resistance was common amongst the Nigerian isolates and was associated with several plasmids, including the IncHI1 plasmid commonly associated with S. Typhi. CONCLUSIONS: These data indicate that typhoid in Nigeria was established through multiple independent introductions into the country, with evidence of regional spread. MDR typhoid appears to be evolving independently of the haplotype H58 found in other typhoid endemic countries. This study highlights an urgent need for routine surveillance to monitor the epidemiology of typhoid and evolution of antimicrobial resistance within the bacterial population as a means to facilitate public health interventions to reduce the substantial morbidity and mortality of typhoid.